{
    "cancelStatus": "1",
    "cancelDate": "2021-02-19",
    "cancelReason": [
        "841"
    ],
    "licid": "52026383",
    "validDate": "2024-08-25 00:00:00.000",
    "issueDate": "2014-08-25 00:00:00.000",
    "licKind": "02",
    "oldLicid": null,
    "certNo": "DHA05202638305",
    "prodNameC": "維提歐膜衣錠100毫克",
    "prodNameE": "Vativio film-coated tablets 100mg",
    "indicationsName": [
        "治療正值急性轉化期（blast crisis）、加速期或經ALPHA-干擾素治療無效之慢性期的慢性骨髓性白血病（CML）患者。治療成年人無法手術切除或轉移的惡性胃腸道基質瘤。用於治療初診斷為慢性骨髓性白血病（CML）的病人。‧治療初診斷為費城染色體陽性急性淋巴性白血病（Ph+ALL）且併用化療之成年及兒童患者。‧做為治療成人復發性或難治性費城染色體陽性急性淋巴性白血病（Ph+ALL）之單一療法。‧治療患有與血小板衍生生長因子受體（PDGFR）基因重組相關之骨髓發育不全症候群（MDS）\/骨髓增生疾病（MPD）之成人患者。‧治療患有系統性肥大細胞增生症（SM），限具FIPILI-PDGFR基因變異且不具有c-Kit基因D816V突變之成人患者。‧治療嗜伊紅性白血球增加症候群（HES）與\/或慢性嗜伊紅性白血病（CEL）且有血小板衍生生長因子受體（PDGFR）基因重組之成人患者。‧作為成人KIT（CD 117）陽性胃腸道基質瘤完全切除後（complete gross resection）之術後輔助治療。‧治療無法手術切除、復發性或轉移性且有血小板衍生生長因子受體（PDGFR）基因重組之隆突性皮膚纖維肉瘤（DFSP）之成人患者。"
    ],
    "does": "1116",
    "packageUnit": [
        {
            "packageSpec": "8-1000錠",
            "packageUnit": "89"
        }
    ],
    "medMCode": "06",
    "maMedCode": "",
    "medDCode": null,
    "ingredientsDesc": [
        "IMATINIB MESYLATE"
    ],
    "restraintItemsCode": [
        "02",
        "24"
    ],
    "applicantName": "瑞士商愛爾康大藥廠股份有限公司台灣分公司",
    "applicantAddr": "台北市中正區仁愛路二段99號11樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": null,
    "mdKind": [],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "factoryCode": "1",
            "factoryName": "NOVARTIS PHARMA PRODUKTIONS GMBH",
            "factoryAddr": "OEFLINGERSTRASSE 44, 79664 WEHR, GERMANY",
            "factoryCompanyAddr": "",
            "countryCode": "DE",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FDE0239000",
            "factoryInfo": null,
            "qsd": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "1013000710",
            "ingredientsDesc": "IMATINIB MESYLATE",
            "concentDesc": "(eq. to Imatinib 100mg)",
            "concent": "119.500",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [
        {
            "licChgDocId": "44367B13-EF9A-437F-BE42-B2F356D1F402",
            "approvedDocNo": "1096023506",
            "approvedDate": "2020-10-26",
            "changeItem": null,
            "changeRecord": null,
            "remark": ""
        },
        {
            "licChgDocId": "34B3EFCB-18AC-4577-84C1-280E8E8FFC93",
            "approvedDocNo": "9999999999",
            "approvedDate": "2020-06-10",
            "changeItem": null,
            "changeRecord": null,
            "remark": ""
        },
        {
            "licChgDocId": "472A2B8C-B062-4E84-81BC-C76BE447C346",
            "approvedDocNo": "9999999999",
            "approvedDate": "2020-02-24",
            "changeItem": null,
            "changeRecord": null,
            "remark": ""
        },
        {
            "licChgDocId": "BA8888CB-B0FF-4B41-A684-510637B9C10E",
            "approvedDocNo": "1081491454",
            "approvedDate": "2020-02-04",
            "changeItem": null,
            "changeRecord": null,
            "remark": ""
        },
        {
            "licChgDocId": "CC922388-D07C-4BBC-8C78-8FAF5DE05CD6",
            "approvedDocNo": "9999999999",
            "approvedDate": "2019-09-11",
            "changeItem": null,
            "changeRecord": null,
            "remark": ""
        }
    ],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L01EA01"
        }
    ],
    "licBaseId": "34346233-3263-4C29-AB30-37AB3F56BB5E"
}